| 141 |
|
ASTHMA - Other Therapies - Magnesium sulfate as a vehicle for nebulized salbutamol in acute asthma/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 142 |
|
ASTHMA - Other Therapies - Treatment of allergic asthma with monoclonal anti-IgE antibody/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 143 |
|
ASTHMA - Pathophysiology - CD4+ T helper cells engineered to produce latent TGF-B1 reverse allergen-induced airway hyperreactivity and inflammation/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 144 |
|
ASTHMA - Pathophysiology - Eosinophilia at the time of RSV bronchiolitis predicts childhood reactive airway disease/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 145 |
|
ASTHMA - Pathophysiology - Induced sputum: Comparison of postinfectious cough with allergic asthma in children/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 146 |
|
ASTHMA - Pathophysiology - Prostaglandin D2 as a mediator of allergic asthma/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 147 |
|
ASTHMA - Pathophysiology - Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitization in infants at high risk of asthma/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 148 |
|
ASTHMA - Pathophysiology - Respiratory syncytial virus (RSV) bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 149 |
|
ASTHMA - Pathophysiology - Rhinovirus infects the lower airways/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 150 |
|
ASTHMA - Steroid Therapy - A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in children/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 151 |
|
ASTHMA - Steroid Therapy - Comparison of efficacy and safety between flunisolide/Aerochamber and budesonide/Tutbuhaler in patients with moderate asthma/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 152 |
|
ASTHMA - Steroid Therapy - Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by Diskus device in patients treated with or without inhaled corticosteroids/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 153 |
|
ASTHMA - Steroid Therapy - Effect of long-term treatment with inhaled budesonide on adult height in children with asthma/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 154 |
|
ASTHMA - Steroid Therapy - Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 155 |
|
ASTHMA - Steroid Therapy - Inhaled corticosteroid therapy is safe in tuberculin-positive asthmatic children/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 156 |
|
ASTHMA - Steroid Therapy - Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 157 |
|
ASTHMA - Steroid Therapy - Long-term effects of budesonide or nedocromil in children with asthma/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 158 |
|
ASTHMA - Steroid Therapy - Low- and high-dose fluticasone propionate in asthma: Effects during and after treatment/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 159 |
|
ASTHMA - Steroid Therapy - Low-dose inhaled corticosteroid and the prevention of death from asthma/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|
| 160 |
|
ASTHMA - Steroid Therapy - Optimal asthma control starting with high doses of inhaled budesonide/
|
|
American Academy of Pediatrics [etc.]
|
2001
|
|
|
|